Keywords: strong, ph, iii, study, data, biomarin, pku

Strong Ph III study data for BioMarin's PKU drug

Article | 20 August 2007

Print This

The USA's BioMarin Pharmaceutical has reported positive final results from a Phase III trial of Kuvan (sapropterin). The data, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in